# Newronika wins CE mark for AlphaDBS adaptive deep brain stimulation for Parkinson's

Canonical page: https://technooptimist.io/stories/newronika-wins-ce-mark-for-alphadbs-adaptive-deep-brain-stimulation-for-e8a45123
Date: 24 Mar 2025
About: [Newronika](https://technooptimist.io/companies/newronika.md) · [AlphaDBS (αDBS)](https://technooptimist.io/neurotech/alphadbs.md)
Original source: https://www.prnewswire.co.uk/news-releases/newronika-receives-ce-mark-approval-for-alphadbs-advancing-adaptive-deep-brain-stimulation-for-parkinsons-disease-302408082.html

Newronika's AlphaDBS, a closed-loop system that adjusts stimulation from real-time brain signals, received the CE mark. The company says clinical data showed adaptive DBS gave patients more time without symptoms or side effects than conventional DBS, and planned a launch in select European markets in 2025.

## Key facts

- Approval based on safety and effectiveness data; the release gives no figures
- Newronika had recently received an FDA IDE to start a pivotal US trial
- Quoted: Lorenzo Rossi, CTO and co-founder

---

The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt).
Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.